Effect of growth hormone replacement therapy on bone mass, bone metabolism, and body composition in adult patients with growth hormone deficiency

Current Therapeutic Research - Clinical and Experimental

Volumn 60, Issue 4, 1999, Pages 237-249

  Lirisetto, Giovanni ^a,c   Zaccaria, Marco ^a   Cestaro, Stefania ^a   Camozzi, Valentina ^a   Angelini, Federico ^b   Moisé, Manuela ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^c Dept of Med and Surgical Sciences Division of Endorcinology   (Italy)

Author keywords

Body composition; Bone mineral density; Growth hormone replacement therapy; Hypopituitarism

Indexed keywords

ALKALINE PHOSPHATASE; HUMAN GROWTH HORMONE; OSTEOCALCIN; PLACEBO;

ADULT; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BODY COMPOSITION; BODY FAT; BONE DENSITY; BONE DEVELOPMENT; BONE MASS; BONE METABOLISM; BONE MINERAL; BONE TURNOVER; CLINICAL ARTICLE; FEMALE; GROWTH HORMONE DEFICIENCY; HORMONE ACTION; HORMONE SUBSTITUTION; HUMAN; LEAN BODY WEIGHT; MALE; PRIORITY JOURNAL;

EID: 0032916362     PISSN: 0011393X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0011-393X(00)88519-7     Document Type: Article

References (31)

1. 1. Bouillon R. Growth hormone and bone. Horm Res. 1991;36(Suppl 1):49-55.
2. 2. Parfitt AM, Growth hormone and adult bone remodelling. Clin Endocrinol. 1991;35:467-470.
3. 3. Rossini M, Zamberlan N, Gatti D, et al. Acute bone response to exogenous growth hormone after bisphosphonate treatment. J Clin Invest. 1995;18(Suppl 5):274. Abstract.
4. 4. Aloia JF, Vaswani A, Meunier PJ, et al. Coherence treatment of post-menopausal osteoporosis with growth hormone and calcitonine. Calcif Tissue Int. 1987;40:253-259.
5. 5 Van der Veen EA, Netelembos JC. Growth hormone (replacement) therapy in adults: Bone and calcium metabolism. Horm Res. 1990;33(Suppl 4):65-68.
6. 6. Valk NK, Erdtsieck RJ, Algra D, et al. Combined treatment of growth hormone and the bisphosphonate pamidronate, versus treatment with GH alone, in GH-deficient adults: The effects on renal phosphate handling, bone turnover and bone mineral mass. Clin Endocrinol. 1995;43:317-324.
7. 7. Wüster C. Growth hormone and bone metabolism. Acta Endocrinol. 1993;128(Suppl 2): 14-18.
8. 8. Beshyah SA, Thomas E, Kyd P, et al. The effect of growth hormone replacement therapy in hypopituitaric adults on calcium and bone metabolism. Clin Endocrinol. 1994;40:383-391.
9. 9. Wollmann HA, Schönan E, Blum WF, et al. Dose-dependent response in insulin-like growth factors, insulin-like growth-factor-binding protein-3 and parameters of bone metabolism to growth hormone deficiency. Horm Res. 1995;43:249-256.
10. 10. Shore RM, Chesney RW, Mazess PB, et al. Bone mineral status in growth hormone deficiency. J Pediatr. 1980;96:393-396.
11. 11. Cuneo RC, Salomon F, McGauley GA, Sönksen PH. The growth hormone deficiency syndrome in adults. Clin Endocrinol. 1992;37:387-397.
12. 12. Rosen T, Hansson T, Granhed H, et al. Reduced bone mineral content in adult patient with growth hormone deficiency. Acta Endocrinol. 1993;129:201-206.
13. 13. Rudman D, Feller AG, Nagraj HS, et al. Effects of human growth hormone in man over 60 years old. NEJM. 1990;323:1-6.
14. 14. Eriksen EF, Kassem M, Brixen K. Growth hormone and insulin-like growth factors as anabolic therapies for osteoporosis. Horm Res. 1993;40:95-98.
15. 15 Carter DR, Bouxei ML, Marcus R New approaches for interpreting projected bone densitometry data. J Bone Miner Res. 1992;7:137-145.
16. 16. Schlemmer A, Johansen JS, Pedersen JA, et al. The effect of growth hormone (GH) therapy on urinary pyridoline cross-links in Gil-deficient adults. Clin Endocrinol. 1991; 35:471-476.
17. 17. Binnerts A, Swart GR, Wilson JHP, et al. The effect of growth hormone administration in growth hormone deficient adults on bone, protein, carbohydrate and lipid homeostasis, as well as on body composition. Clin Endocrinol. 1992;37:79-87.
18. 18. Vandeweghe M, Taelman P, Kaufman JM. Short and long-term effects of growth hormone treatment on bone turnover and bone mineral content in adult growth hormone-deficient males. Clin Endocrinol. 1993;39:409-415.
19. 19. Sartorio A, Conti A, Monzani M. et al. Growth hormone treatment in adults with GH deficiency: Effects on new biochemical markers of bone and collagen turnover. J Endocrinol Invest. 1993;16:893-898.
20. 20. Sartorio A, Conti A, Monzani M, et al. Growth hormone treatment in adults with GH deficiency: Effects on muscle size, strength and bone turnover. Front Endocrinol. 1994; 9:219-224.
21. 21. Wüster C, Pereira-Lima JF, Seibel MJ, et al. Increased bone area and decreased body fat after growth hormone therapy in adult-onset growth hormone deficiency. Exp Clin Endocrinol Diabetes. 1996;104:159. Abstract.
22. 22. O'Halloran D, Tsatsoulis A, Whitehouse RW, et al. Increased bone density after recombinant human growth hormone (GH) therapy in adults with isolated GH deficiency. J Clin Endocrinol Metab. 1993;76:1344-1348.
23. 23. Salomon F, Cuneo RC, Hesp R. The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency. NEJM. 1989;321:1797-1803.
24. 24. Jorgensen JOL, Pederson SA. Beneficial effects of growth-hormone treatment in GH-deficient adults. Lancet. 1989;1:1212-1224.
25. 25. Bengtsson B, Eden S, Lönn L, et al. Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J Clin Endocrinol Metab. 1993;76:309-317.
26. 26. Jorgensen JOL, Thuesen L, Müller J, et al. Three years of growth hormone treatment in growth hormone-deficient adults: Near normalization of body composition and physical performances. Eur J Endocrinol. 1994;130:224-228.
27. 27. Rosen T, Johannsson G, Bengtsson BA. Consequences of growth hormone deficiency in adults, and effects of growth hormone replacement therapy. Acta Paediatr. 1994; 399(Suppl):21-24.
28. 28. Beshyah SA, Froemantle C, Shahit M, et al. Replacement treatment with biosynthetic human growth hormone in growth hormone-deficient hypopituitary adults. Clin Endocrinol. 1995;42:73-84.
29. 29. Young D, Hopper JL, Nowson CA, et al. Determinants of bone mass in 10-to 26-year-old females: A twin study. J Bone Miner Res. 1995;10:558-567.
30. 30. Parfitt AM. Osteonal and hemi-osteonal remodeling: The spatial and temporal frame-work for signal traffic in adult human bone. J Cell Biochem. 1994;55:273-286.
31. 31. Holmes SJ, Whitehouse RW, Economon G, et al. Further increase in forearm cortical bone mineral content after discontinuation of growth hormone replacement. Clin Endocrinol. 1995;42:3-7.